Daycare chemo centres in Karnataka's 16 districts to improve cancer care
Bengaluru: The govt will launch daycare chemotherapy centres in 16 districts to improve access to cancer treatment and reduce the burden on tertiary hospitals. The initiative aims to address the challenges faced by cancer patients, particularly those from rural areas.
Health minister Dinesh Gundu Rao said: "Karnataka records approximately 70,000 new cancer cases annually. The most common cancers are breast (18%), cervical (14%), oral (12%), lung (8%) and colorectal (6%). Oral cancer incidence in the state stands at 12 cases per 1 lakh population, which is higher than the national average, while the incidence of breast cancer is 35 cases per 1 lakh women population."
Statistics provided by the department revealed that 60% of cancer patients travel over 100km to access chemotherapy services in cities like Bengaluru, Hubballi and Mysuru.
"We saw high dropout rates — 30% — due to cost and logistics of repeated visits," he said.
According to the minister, the new centres will be set up under hub-and-spoke model, in which tertiary care hospitals will serve as hubs and district-level hospitals will act as spokes. In Karnataka, they will be set up through an MoU between tertiary care centres and district daycare chemotherapy centres (DCCCs). The hubs will handle complex procedures and diagnostics, while DCCCs will provide outpatient chemotherapy, palliative care, counselling and basic laboratory investigations.
by Taboola
by Taboola
Sponsored Links
Sponsored Links
Promoted Links
Promoted Links
You May Like
월 2만원으로 저소득 아이들의 한끼 선물하기
굿네이버스
더 알아보기
Undo
"The centres are expected to reduce travel time for patients, bring down out-of-pocket expenses by an estimated 40% and improve treatment adherence by making services more accessible. For hospitals, it will decongest the burden on tertiary centres," he explained.
Each DCCC will be staffed with a visiting medical oncologist, two trained nurses, physician, pharmacist and counsellor. Drug procurement will follow standardised protocols based on the essential medicines list issued by Suvarna Arogya Suraksha Trust (SAST).
"The districts where DCCCs are being established are Bagalkot, Ballari, Bengaluru Urban/Rural, Ramanagara, Chitradurga, Dakshina Kannada, Davanagere, Dharwad, Haveri, Kolar, Mysuru, Tumkur, Udupi, Vijayanagara and Vijayapura," the minister added.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
35 minutes ago
- Time of India
New COVID variant NB.1.8.1 spreading fast in the U.S — is your vaccine effective? Will there be a summer surge?
A new COVID variant, NB.1.8.1, is gaining traction in the United States just as summer approaches. Despite its rarity, it appears to be more transmissible than current strains. While not yet dominant, officials are closely monitoring its expansion and potential impact on public health. Although experts say it's too soon to predict whether the virus will lead to more COVID cases this summer, health officials are closely monitoring the variant as it spreads throughout the world. NB.1.8.1 is categorized by the World Health Organization (WHO) as a "variant under monitoring." A descendant of the Omicron JN.1 lineage, NB.1.8.1 was first identified in late January and has experienced a dramatic increase in cases worldwide in recent weeks, as per a report by Health. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Mountain Gear for Extreme Conditions Trek Kit India Learn More Undo How serious is NB.1.8.1 compared to other variants? The WHO's latest data shows that between April 21 and April 27, 10.7% of all sequenced COVID cases worldwide were caused by NB.1.8.1, up from 2.5% just one month earlier. According to Shira Doron, MD, chief infection control officer at Tufts Medicine, the variant is genetically distinct from LP.8.1, the dominant strain currently found in the United States. Live Events The variant may increase cases this summer because it seems more contagious than LP.8.1, the strain that is most prevalent globally. It appears to be no more effective than LP.8.1, though, at avoiding immunity from vaccinations or previous infections. The World Health Organization (WHO) has concluded that it does not present an additional health risk because it has not discovered any evidence that it causes more serious illness. What are the symptoms of NB.1.8.1? Experts concur that NB.1.8.1 symptoms resemble those of other COVID infections. The majority of NB.1.8.1 patients should anticipate the following symptoms: Chills or fever, coughing, congestion and sore throat, weariness, breathing difficulties and diarrhea. The good news is that NB.1.8.1 doesn't seem to make people sicker than earlier versions. Could there be a summer COVID surge? While now accounting for only a small portion of U.S. cases, specialists are closely monitoring NB.1.8.1. Six spike protein mutations are present in the variation, which may improve its ability to spread and elude antibodies. According to Amy Edwards, MD, an infectious disease specialist and assistant professor of pediatrics at the Case Western Reserve University School of Medicine, those mutations and early data point to NB.1.8.1 being marginally more transmissible, as per a report by NBC News. However, because of NB.1.8.1 or another variation, the number of COVID cases in the United States is probably going to increase this summer. Over the past few years, COVID has experienced two significant increases: one in the mid-to-late summer and another in the winter, Schaffner said, in contrast to influenza, which has one significant increase annually in the winter. Are NB.1.8.1 and current vaccines still effective? Experts say that current vaccines provide some protection, and the variant does not appear to be more severe. Some protection against NB.1.8.1 should come from preexisting immunity from vaccinations or previous infections. The Food and Drug Administration has asked drugmakers to update Covid vaccines to target the LP.8.1 variant this fall. Data from Pfizer and Moderna suggest the updated vaccines would offer protection against NB.1.8.1 as well. However, the FDA has said it will limit its approval of updated Covid shots to older adults and younger people with a medical condition that puts them at risk of severe illness. Doctors worry that pregnant people and children under 5 may be vulnerable to severe outcomes from Covid this winter. Even healthy adults who've been vaccinated before might not have optimal protection. According to Doron, new COVID booster shots from Pfizer, Moderna, and Novavax are also being developed and should be available in the early fall. Preliminary results indicate that they will be effective against NB.1.8.1 and other more prevalent strains in the United States. FAQs Does the new variant result in more severe illness? No, NB.1.8.1 does not appear to result in more severe symptoms than previous variants. Will current vaccines protect me from it? Yes, existing vaccines and boosters should provide some protection against NB.1.8.1.
Time of India
2 hours ago
- Time of India
Haribo recalls sweets in Netherlands after cannabis found
Representative AI image On Thursday, the German-based candymaker Haribo recalled its Happy Cola F!ZZ sweets in the Netherlands after cannabis was found in at least three bags containing the product. The recall only applies to 1-kilogram (2.2-pound) bags sold in the Netherlands. Haribo has asked customers to return Happy Cola F!ZZ candies with a best-before date (BBD) of January 2026 and the product code L341-4002307906 for a refund. Despite the low number of products found to contain cannabis, the Dutch Food and Consumer Product Safety Authority (NVWA) said Haribo had issued a complete batch recall as a precaution. "There are bags in circulation with sweets that can lead to health complaints, such as dizziness, when consumed," NVWA spokesperson Saida Ahyad said. "The police reported this to the NVWA after several people, both children and adults, became ill after eating the cola bottles," Ahyad said. "Do not eat the sweets," Ahyad added. Haribo working with Dutch authorities Haribo said it was actively working with authorities to find out how the cannabis made its way into the company's products. "The safety of our consumers is our highest priority, and Haribo takes this incident very seriously," Haribo's vice president of marketing, Patrick Tax, told the AFP news agency. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Buy Brass Idols - Handmade Brass Statues for Home & Gifting Luxeartisanship Buy Now Undo "This is a live issue and we are working closely with the Dutch authorities to support their investigation and establish the facts around the contamination," Tax said. The internationally renowned sweets manufacturer has been producing its cola bottles since 1965, promising that "every bottle conceals a little adventure of its own."
Time of India
3 hours ago
- Time of India
'Life-threatening' bacteria found in invasive tick for first time in US. Know about human monocytic ehrlichiosis
A new report shows the first evidence in the United States of the invasive longhorned tick with Ehrlichia chaffeensis , a potentially life-threatening pathogen, was found in recent years in Connecticut. As outdoor activities ramp up with the approach of summer, Connecticut officials announced Tuesday that they have confirmed the first US case of the invasive longhorned tick carrying Ehrlichia chaffeensis, a bacterium that can cause a potentially fatal illness, according to New York Post. The Centers for Disease Control and Prevention (CDC) said human monocytic ehrlichiosis , or HME, usually spreads by the lone star tick, which is native to the US and found throughout most of the eastern, southeastern, and south-central parts of the country. ALSO READ: TACO Trump: Jimmy Kimmel brutally trolls President on his show, asks 'How does it feel?' by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like New Container Houses Indonesia (Prices May Surprise You) Container House | Search ads Search Now Undo What are the symptoms of monocytic ehrlichiosis? HME disease initially causes symptoms such as sudden high fever, chills and fatigue a few weeks after an infection, according to officials with the Connecticut Agricultural Experiment Station (CAES). Symptoms may progress to include symptoms such as nausea, confusion and, ultimately, kidney failure and respiratory complications. However, the recent case of a tick carrying Ehrlichia chaffeensis, the bacteria behind HME, in Connecticut involved the longhorned tick, a tick species native to eastern Asia. Live Events ALSO READ: 'Abused, dragged and choked': Sean Diddy forced his ex into freak-offs, threatened to leak tapes and ruin her career Officials stated that this species plays a major role in carrying the bacteria and spreading HME, especially as it is expected to expand across the eastern United States. They explained that its rapid spread is largely due to its ability to reproduce without a male and its broad, unrestricted feeding habits. 'The first fully engorged human-parasitizing longhorned tick specimen was recorded by the CAES in 2018 from Fairfield, Connecticut, and the first populations of the tick were reported from this county in 2020,' said Dr. Goudarz Molaei, director of the CAES Passive Tick and Tick-Borne Disease Surveillance Program. ALSO READ: Popular ice cream chain to close 500 stores in US amid bankruptcy proceedings Since then, longhorned tick populations have spread across several towns in Fairfield and New Haven Counties. Isolated specimens have also been found in New London and other areas. Officials have raised concerns about the species' ability to expand its range and its potential to carry pathogens that pose risks to the health of humans, pets, and other animals. They emphasized that longhorned ticks in the U.S. have been linked to the transmission of various pathogens, including those responsible for Lyme disease.
